Vermú de nanociencia 2021: NANOMEDICINE Solution to Mitigate HIV AIDS скачать в хорошем качестве

Vermú de nanociencia 2021: NANOMEDICINE Solution to Mitigate HIV AIDS

Dr Maluta Steven Mufamadi, Founder and Managing Director at Nabio Consulting PTY LTD Short-Bio: Dr Mufamadi is the founder and managing director of Nabio Consulting (Pty) Ltd. He has earned his PhD in Pharmaceutics from Wits University, entrepreneurship short courses from University of Pretoria and Ecole Polytechique Federale de Lausanne (EPFL), Switzerland. He has authored and co-authored three patents, one of which is an international patent, several peer-reviewed scientific publication and chapters. Book editor: Green synthesis in nanomedicine and human health. He received several awards including: International inventor from the Wits Enterprise & Wits University Innovation Forum, the best peer-reviewed research paper of pharmaceutics from the Academy of Pharmaceutical Sciences of South Africa (APSSA), Gauteng Biotech communicator of the year by the BioFundi awards in 2017 and finalist of the 2019/2020 NSTF South 32 Awards in the category: Communication award. In 2017, he was supported for UNESCO- Kalinga Prize for the popularization of nanotechnology in South Africa by the South African National Commission for UNESCO. He is also a Member of the South African Bureau of Standards (SABS) committee on nanotechnologies and Expert Technical Committee for Working Group 5 of ISO/TC 229 on nanotechnologies. He has served as a consultant for many organisations, embassies, government departments, agencies, SMMEs and pharmaceutical companies, both local and international. He co-founded several dialogues on communicable and non-communicable diseases such as cancer medicine in the era of the Fourth Industrial Revolution (4IR) and COVID-19 vaccine policy dialogue. He also co/founded the South Africa Nanotechnology Symposia series (HIV/AIDS, TB, Malaria, Cancer and Energy), South Africa and Switzerland nanomedicine symposium, South Africa and Italy nanomedicine webinar, and International Nano4Youth seminar. Title: Nanomedicine: Solution to Mitigate HIV/AIDS Short description of the talk Currently, there is no cure and no preventive vaccine for HIV/AIDS. Combination antiretroviral therapy has played pivotal role in the reduction of HIV/AIDS-related morbidity and mortality, however, it has major side effects and is ineffective in patients in whom the virus develops resistance. Nanotechnology has been recognised as one of the most important scientific fields of the 21st century, using engineered structures of the nanometre-scale size range (1-100nm) to the benefit of mankind. Nanomedicine is the application of nanotechnology to the field of medicine, has demonstrated the potential to revolutionise modern medicine through advancing the treatment and prevention of HIV/AIDS. Five nanotechnology-based strategies that have a potential to eliminate HIV in the reservoirs and/or prevent virus entry into the immune system cells, such include; i) “Nano-Antiretroviral” strategy, ii) “Shock and Kill” strategy, iii) “Block and Lock” strategy, iv) “Silence and Block” strategy and v) “Hijack and Block” strategy.